Retrospective Study
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 98228
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.98228
Table 1 Recipients’ baseline characteristics stratified by frail group, n (%)
Frailty status, recipients’ characteristics
Total (n = 37427)
Frail group (n = 30943)
Non-frail group (n = 6484)
P value
Age groups< 0.001a
    18-34 years957 (2.6)850 (2.7)107 (1.7)
    35-49 years7092 (18.9)6075 (19.6)1017 (15.7)
    50-64 years23529 (62.9)19248 (62.2)4281 (66.0)
    > 64 years5849 (15.6)4770 (15.4)1079 (16.6)
Gender< 0.001a
    Male25696 (68.7)20700 (66.9)4996 (77.1)
    Female11731 (31.3)10243 (33.1)1488 (22.9)
Race< 0.001a
    White26542 (70.9)21993 (71.1)4549 (70.2)
    Black or African American3267 (8.7)2611 (8.4)656 (10.1)
    Hispanic Latino5720 (15.3)4942 (16.0)778 (12.0)
    Others1898 (5.1)1397 (4.5)501 (7.7)
Body mass index (kg/m2), mean (SD)29.1 (6.0)29.1 (6.1)29.0 (5.5)0.429
Primary diagnosis< 0.001a
    Viral14003 (37.4)10629 (34.4)3374 (52.0)
    Alcohol-associated10940 (29.2)9624 (31.1)1316 (20.3)
    Non-alcoholic steatohepatitis7132 (19.1)6181 (20.0)951 (14.7)
    Other/mixed5352 (14.3)4509 (14.6)843 (13.0)
Model for end-stage liver disease score, unit, mean (SD)23.3 (10.0)24.7 (9.8)16.7 (7.6)< 0.001a
Ventilator< 0.001a
    No35831 (95.7)29357 (94.9)6474 (99.8)
    Yes1596 (4.3)1586 (5.1)10 (0.2)
Warm ischemic time, minute, mean (SD)40.4 (20.1)40.6 (20.6)39.8 (18.4)0.029a
Death indicator after transplant0.022a
    Death7955 (21.3)6508 (21.0)1447 (22.3)
    Non-death29472 (78.7)24435 (79.0)5037 (77.7)
Functional status at transplant in Karnofsky Performance Score scale-
    Normal6484 (17.3)0 (0.0)6484 (100.0)
    Moderate14957 (40.0)14957 (48.3)0 (0.0)
    Severe15986 (42.7)15986 (51.7)0 (0.0)